Ruby Lin Suing Hospital for Unauthorized Hymen Repair Ad
After discovering that her photo was used online in an illustration of a hymen repair surgery, Ruby Lin (林心如) is suing the Beijing Greene Hospital for copyright infringement. The trial began yesterday morning in the Court of Chaoyang.
Ruby believes that a popular actress as herself represents excellent marketing value as a spokesperson. In July of this year, Ruby discovered that in one of their online articles, the Beijing Greene Hospital, had used her image for the illustration for their hymen repair surgery service without her permission.
The copyright infringement has already lasted for 2 years, and Ruby believes her reputation was seriously damaged.
Yesterday morning, Ruby entrusted two lawyers to appear in court. Ruby is requesting damages for the use of her image without her consent, and is suing for monetary damage. In addition, Ruby expects an apology. Based on accepted celebrity spokesperson fees, the lawyer said she will be suing for $500,000 RMB, plus $100,ooo RMB for mental distress. The lawyer said, “Ruby will never appear in this kind of advertisement (hymen repair surgery). Even if money is offered, Ruby will turn it down.”
During the trial, the Beijing Greene Hospital claimed that although the website has their name on it, it is not affiliated with them. They claimed that they have never administered nor accessed the site.
This article is written by Lance for JayneStars.com.
Note: This article is written for JayneStars.com. DO NOT re-post this article on any other websites. No part of this article may be copied, reproduced, rearranged, redistributed, modified by any means or in any form whatsoever without prior written permission. You may use the content online and for your non-commercial, personal use only. Copying these materials for anything other than your personal use is a violation of copyright laws.
Should you wish to share this article, we recommend that you: (i) link directly to the article at JayneStars.com on your website; or (ii) share this article link via social media sites such as Facebook and Twitter.